Synapticure vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Chicago virtual care for ALS, Alzheimer's, and Parkinson's patients across 50 states; YC $46.3M B Capital/Google Ventures/CommonSpirit-backed as CMS GUIDE dementia provider competing with specialty neurology for neurodegenerative disease management.
About
Synapticure is a Chicago, Illinois-based virtual care company — backed by Y Combinator with $46.3 million raised including a $25 million Series A led by B Capital in November 2024, with prior investment from CommonSpirit Health, CVS Health Ventures, RA Capital, Google Ventures, Optum Ventures, and Rock Health — providing patients with ALS, Alzheimer's disease, Parkinson's disease, frontotemporal dementia (FTD), Huntington's disease, and other neurodegenerative conditions with specialized virtual neurology care, genetic counseling, AI-powered diagnostic support, care coordination, and 24/7 patient and caregiver support across all 50 US states. Synapticure serves as a nationwide CMS GUIDE (Guiding an Improved Dementia Experience) model provider for Alzheimer's patients — a Centers for Medicare & Medicaid Services innovation program that provides reimbursement for comprehensive dementia care management outside of traditional fee-for-service neurology visits.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.